Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.44 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27575789 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL8686086 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL9949418 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL10398805 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL4141309 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL8685807 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL4286294 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL8685954 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL21541577 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 | |
| SCHEMBL3854136 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRANPEPERAP2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118696933-A | Low-toxicity compound bactericide and preparation method and application thereof | 中国日用化学研究院有限公司 | 2024-09-27 | — | — | CN | disclosed |
| US-11166899-B2 | Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex | AMOREPACIFIC CORPORATION (KR) | 2021-11-09 | — | — | US | disclosed |
| US-20200179260-A1 | COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX | AMOREPACIFIC CORPORATION (KR) | 2020-06-11 | — | — | US | disclosed |
| CN-110996897-A | Skin external composition containing ceramide, its derivative and cortex Hibisci extract | 株式会社爱茉莉太平洋 | 2020-04-10 | — | — | CN | disclosed |
| CN-103769307-A | Collecting agent for water-soluble cations, preparation method thereof and application thereof | UNIV NORTHEASTERN | 2014-05-07 | — | — | CN | disclosed |
| US-6060612-A | SKIN CARE COSMETIC | PACIFIC CORPORATION (KR) | 2000-05-09 | — | — | US | disclosed |
| EP-0882056-A2 | PREPARATION OF SURFACE-ACTIVE COMPOUNDS BASED ON LACTOSE | COÖPERATIEVE WEIPRODUKTENFABRIEK "BORCULO" W.A. (NL) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997030063-A2 | PREPARATION OF SURFACE-ACTIVE COMPOUNDS BASED ON LACTOSE | COÖPERATIEVE WEIPRODUKTENFABRIEK 'BORCULO' W.A. (NL) | 1997-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11166899-B2 | Composition for external application containing a ceramide, a derivative thereof and an extract of Hibisci cortex | CERT1, CERS2, SGMS1 | ALDH1A1 3828/4885TSHR 4858/4885ANPEP 3513/4885 |
| US-20200179260-A1 | COMPOSITION FOR EXTERNAL APPLICATION CONTAINING A CERAMIDE, A DERIVATIVE THEREOF AND AN EXTRACT OF HIBISCI CORTEX | CERT1, CERS2, SGMS1 | ALDH1A1 3828/4885TSHR 4858/4885ANPEP 3513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.